Pharming Receives Japanese Patent on Recombinant Human Lactoferrin
10 août 2005 01h36 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Aug. 10, 2005 (PRIMEZONE) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHAR.AS), a biotechnology company, announced today that it has been granted a...
Pharming Announces Research Collaboration With NovaThera
12 juil. 2005 01h12 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, July 12, 2005 (PRIMEZONE) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) (PHARM.AS) announced today a research collaboration with NovaThera Limited...
Pharming to Receive Milestone Payment from Esteve
04 juil. 2005 02h07 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, July 4, 2005 (PRIMEZONE) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) announced today that it will receive a milestone payment from Laboratorios del Dr....
Pharming Announces Partnership With AgResearch For Human Lactoferrin
30 juin 2005 01h05 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, June 30, 2005 (PRIMEZONE) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) (PHAR.AS) announced today a partnership with AgResearch Limited ("AgResearch") on...
Pharming Announces Key Appointments To Strengthen Organization
24 juin 2005 12h24 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, June 24, 2005 (PRIMEZONE) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) announced key appointments to further strengthen its organization in preparation...
Pharming Announces First Quarter 2005 Results
06 mai 2005 01h41 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, May 6, 2005 (PRIMEZONE) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) (PHAR.AS) announced today its first quarter (Q1) results for the period ended March...
Pharming Presents Phase II / III Clinical Results With Recombinant Human C1 Inhibitor
02 mai 2005 01h38 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, May 2, 2005 (PRIMEZONE) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) (PHAR.AS) announced today clinical results from Phase II/III clinical studies with...
Pharming Receives Over 800,000 Shares from Trust Foundation
29 avr. 2005 12h17 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, April 29, 2005 (PRIMEZONE) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) (PHAR.AS) announced today that the Company is the beneficiary of over 800,000...
Pharming Announces Annual Shareholders Meeting
22 avr. 2005 02h06 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, April 22, 2005 (PRIMEZONE) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) (PHAR.AS) announced that the Company's annual shareholders meeting (AGM) will be...
Pharming to Present at UBS Northern Europe Conference
11 avr. 2005 05h34 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, April 11, 2005 (PRIMEZONE) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHAR.AS) announced today that the Company will present at the UBS Northern...